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Abstract 
This review provides an overview of the effect of blood flow on endothelial cell (EC) signalling path-
ways, applying microarray technologies to cultured cells, and in vivo studies of normal and athero-
sclerotic animals. It is found that in cultured ECs, 5–10% of genes are up- or down-regulated in re-
sponse to fluid flow, whereas only 3–6% of genes are regulated by varying levels of fluid flow. Of all 
genes, 90%are regulated by the steady part of fluid flow and 10% by pulsatile components. The as-
sociated gene profiles show high variability from experiment to experiment depending on experi-
mental conditions, and importantly, the bioinformatical methods used to analyse the data. Despite 
this high variability, the current data sets can be summarized with the concept of endothelial priming. 
In this concept, fluid flows confer protection by an up-regulation of anti-atherogenic, anti-thrombotic, 
and anti-inflammatory gene signatures. Consequently, predilection sites of atherosclerosis, which 
are associated with low-shear stress, confer low protection for atherosclerosis and are, therefore, 
more sensitive to high cholesterol levels. Recent studies in intact non-atherosclerotic animals con-
firmed these in vitro studies and suggest that a spatial component might be present. Despite the large 
variability, a few signalling pathways were consistently present in the majority of studies. These 
were the MAPK, the nuclear factor-κB, and the endothelial nitric oxide synthase-NO pathways. 
 
Keywords: systems biology, mechanobiology, atherosclerosis, gene deconvolution, shear stress 
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1. Introduction 
 
This review provides a nonexhaustive overview of studies that were performed to under-
stand the role of mechanobiology in the initiation and progression of atherosclerosis. After 
providing an introduction to the effect of blood flow on atherosclerosis, arguments will be 
presented to motivate the use of systems biological techniques to study atherosclerosis. 
This is followed by an overview of studies performed using microarrays on cultured en-
dothelial cells (ECs) under fluid flow, or ECs obtained from intact tissue. Finally, we will 
introduce a novel technique used to estimate gene profiles from ECs in atherosclerosis. 
This review does not include work on microRNAs; on shear stress please refer to other 
papers for this topic.1,2 
 
2. The effect of blood flow on atherosclerosis 
 
Coronary heart disease (CHD) is the global leading cause of death. In the UK, acute coro-
nary syndromes cause ~60% of CHD deaths and lead to ~240 000 hospitalizations each 
year, incurring direct healthcare costs of ~£1.7 billion annually. The majority of the mortal-
ity of CHD is related to the rupture of a thin-cap fibro-atheroma (TCFA). The characteris-
tics of a rupture-prone plaque are that of a large and soft lipid-rich, necrotic core covered 
by a thin and inflamed fibrous cap. Associated features include a large plaque size, expan-
sive remodelling preventing luminal obstruction (mild stenosis by angiography), neovas-
cularization, plaque haemorrhage, adventitial inflammation, and a ‘spotty’ pattern of cal-
cifications.3,4 
Importantly, atherosclerotic plaques do not distribute evenly over the arterial system 
but are located at predilection sites (side branches, curved segments, and bifurcations) that 
are caused by changes to the velocity field, most notably velocity vectors of low magnitude 
and of altered direction are associated with atherosclerosis.5–7 Although these studies 
defined a role of biomechanical factors in the ‘initiation’ of atherosclerosis, later work 
indicates an important role for blood flow in the ‘progression’ of atherosclerosis8–11 and 
restenosis after interventions.12,13 Further studies highlighted the possible role of blood 
flow in determining plaque composition, by recognizing the large cellular heterogeneity 
in the longitudinal direction14–17 (Fig. 1). Recently, human pathological and imaging mo-
dalities (optical coherence tomography, virtual histology) confirmed these observations by 
showing that large lipid cores and TCFA predominantly appear upstream of the culprit 
lesions.15,18–23 
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Figure 1. 3-D reconstruction of atherosclerotic mouse carotid showing large 3-D hetero-
geneity in macrophage distribution. Red is high and dark is low. Note that blood flow is 
directed from the left to the right of the page. 
 
To further understand the role of shear stress in plaque formation, we induced two dif-
ferent pro-atherogenic shear stress fields (low, nonoscillatory and low, oscillatory shear 
stress patterns) in a straight vessel of hypercholesteraemic, ApoE–/– mice, and demon-
strated that specific shear stress patterns induced specific plaque compositions in a high-
cholesterol environment. Surprisingly, the low, non-oscillatory shear stress pattern in-
duced TCFAs, whereas the low and oscillatory shear stress induced stable plaques.24–28 Fur-
ther studies, revealed that low-shear stress-induced TCFA formation was associated with 
the presence of adhesion factors,28 chemokines,26 and activating factors for macrophages,25 
indicating that the reduction of blood velocity enhanced uptake and activation of inflam-
matory cells in the plaques. These observations have recently been confirmed in porcine 
coronary arteries and in human carotid and coronary vessels, indicating that blood flow 
and its derivative shear stress (which scales linearly to velocity) are fundamental to deter-
mining plaque composition.15,29,30 
In summary, fluid flow plays an important role in the initiation and progression of ath-
erosclerosis. The close association with plaque progression may be explained by the fact 
that certain velocity patterns determine plaque composition. The important role of blood 
flow in atherogenesis deserves further attention, and the remainder of the paper describes 
the underlying mechanism with respect to the mechanosensitive pathways in ECs. Other re-
views have been published, describing other relevant mechanisms underlying flow-related 
predilection sites.31,32 
 
3. Mechanosensitive signalling pathways in ECs 
 
ECs are known to have 10–15 (cytoskeleton, Cav3.2T-type channels, stretch-dependent 
Na+-channels, stretch-dependent K+-channels, PECAM1, the glycocalyx, G-receptors, cave-
olae, cilia, and membrane fluidity) mechanosensors, and several studies have identified 
that 10–20 signalling pathways are modified by mechanical stimulation. These mechano-
sensitive pathways regulate 10 acknowledged transcription factors, which lead to the ex-
pression of 1000–2000 genes.33–37 The sheer number of mechanosensitive pathways, their 
interactions, and their unknown dynamics in ECs covering a plaque offers a challenging 
problem to identify individual signalling cascades. 
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Classical physiological studies have investigated relatively few components per study; 
for example, a standard experimental protocol in cardiovascular research examines single 
gene functions through the use of transgenic mice. Although interesting and informative, 
it is now becoming increasingly apparent that such studies are not sufficient to explain 
complex processes such as plaque initiation and atherogenesis. Even a relatively simple 
phenomenon, like the formation of a fatty streak, involves multiple cell types (e.g., T-cells, 
macrophages, and the endothelium) and changes in the gene profile of each cell type, prob-
ably involving hundreds to thousands of genes. Probing single proteins will establish their 
functions, but it will not provide a full understanding of their interactions. For this, a multi-
scale analysis in which the activities of all relevant proteins are monitored over time and 
then integrated into a quantitative mathematical model is required to provide a deeper 
understanding of these cellular dynamics. 
A new branch of biology, defined as systems biology, aims to identify the components 
of complex systems and to model their dynamic interactions and behaviour.38–45 This ap-
proach matured after the Human Genome Project provided a list of all human genes, 
which professionalized new technologies such as RNA sequencing, expression microar-
rays, and tandem mass spectrometric analyses of proteins and metabolites. Given the com-
plexity of the cardiovascular system, and of cardiovascular diseases, systems-based ap-
proaches are likely to play an increasingly important role in elucidating the higher-order 
interactions underlying traits such as atherosclerosis, cardiac hypertrophy, heart failure, 
and arrhythmias. 
This paper provides an overview of studies that apply high-throughput techniques and 
bioinformatics to evaluate the effect of blood flow on the initiation and progression of ath-
erosclerosis. This topic was chosen because it is emerging as a new perspective in under-
standing the pathogenesis of atherosclerosis and it is becoming increasingly important, for 
new diagnostics and therapeutic interventions. 
 
4. Microarray studies in ECs 
 
In the last decade, the microarray technology has been used by many investigators to 
explore genomic changes of ECs in response to mechanical perturbations and after over-
expression of genes involved in the regulation of the mechanosensitive signalling cascade 
(Table 1). In vitro experiments were carried out with cells exposed to different shear stress 
regimes,37,46–63 co-cultured with vascular smooth muscle cells (VSMCs),64 virally transduced 
to over-express mechanosensitive genes51,65,66 and/or exposed to inflammatory cytokines52,59 
(Table 1). In addition to cell culture experiments, some groups have also studied changes 
of the endothelial transcriptome in vivo.37,58,61,63,67 These investigations were mainly con-
ducted in pigs, as these animals have similar haemodynamic scales (e.g., Reynold’s num-
bers) as humans. A common strategy to this approach is to firstly assess the fluid flow and 
associated shear patterns, in different geometrical parts of the main arteries, applying a 
combination of imaging and computational fluid dynamics (CFD). Through CFD, flow 
patterns can be modelled and shear stress maps calculated and related to image-derived 
plaque components. 
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Table 1. An overview of studies using microarrays to determine mechanosensitive signalling 
pathways in ECs 
Cell 
type 
Shear 
conditions 
(dyne/cm2) 
Duration 
(h) 
Type 
of 
platform 
Dgene 
(%) Dgene Ref. Year 
Coverage 
(%) 
In vitro cell culture        
Huvec 0, 25 24 cDNA-1 0.22 52 McCormick 
   et al.58 
2001 56 
Huvec 0, 10 24 cDNA-1 2, 0.8 205/86 Garcia- 
Cardena et al.90 
2002 56 
HAEC 1, 13 24 Atlas 20 69 Brooks et al.91 2002 5 
Huvec 0, 25 24 GDA 5.7 230 Dekker et al57 2002 20 
Huvec 0, 13 24 Agilent 5/5.5 1052/1147 Yee et al.85 2008 100 
Huvec 0, 12 24 Affy 16/17 3427/4010 Mun et al.86 2009 100 
Huvec 1, 15 24 Agilent 1 194 Conway et al.70 2010 100 
Huvec 15, 75 24 Illumina 2 303 White et al.72 2011 100 
BAEC 0, 15, 75 24 Affy 3.5, 7 303/603 Dolan et al.73 2012 43 
In vivo ECs in non-atherosclerotic animals      
PAEC DF vs. UF NA cDNA-2 10 2000 Passerini et 
   al.76, Zhang 
   et al.80 
2004 65 
PAEC CEC vs. IEC NA Operon 0.5 52 Zhang et al.80 2008 52 
PAEC Multiple 
   sites 
NA Operon 1.1 133 Civelek et al.78 2009 52 
PAEC 10, 15, 32 NA Operon 7 730 LaMack et al.61 2010 52 
PAEC  NA Operon 11 1300 Civelek et al.79 2011 52 
MAEC LF vs. UF 48 Illumina 2 583 Ni et al.75 2012 100 
In vivo ECs in atherosclerosis       
MAEC OSS vs. LSS 6w/9w Affy 30 6300 Frueh et al.84 2011 100 
HUVEC, human umbilical venous endothelial cells; PAEC, pig arterial endothelial cells; MAEC, murine arte-
rial endothelial cells; BAEC, bovine arterial endothelial cells; tu, turbulence; cDNA-1, a platform of Research 
Genetics, containing 11.397 unique genes; Atlas, a dedicated platform, containing 1086 genes. GDA platform 
has 18 000 constructs. Agilent contains 44.000 60-mers with an unknown coverage. cDNA-2 is a platform of 
Astra Zeneca and contains 13 824 clones. Operon offers a platform with 10 665 clones. Dgene is a differential 
gene expression, which is presented as absolute numbers or as the percentage of number of genes spotted on 
the platform. Susceptible is supposedly low-shear stress region, and atheroprotective a high-shear stress re-
gion. Affy, affymetrix; CEC, coronary endothelial cell; OSS, oscillatory shear stress; LSS, low-shear stress; LF, 
low flow; DF, disturbed flow; UF, undisturbed flow; h, hours; w, weeks. See text for details. 
 
5. Microarray studies in cultured ECs 
 
In 2001, Garcia-Cardena and McCormick et al. were the first groups to address how gene 
expression in human umbilical venous endothelial cells (HUVECs) changes when exposed 
to laminar shear stress. The microarrays of McCormick et al. contained only a restricted 
number of genes, as the entire human genome was not deciphered until 2003. Nevertheless, 
52 genes were found to be differentially expressed, of which 32 genes increased upon 
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exposure to shear stress. The increased gene expression such as cytochrome P450, ASS1, 
and human pGL transporter are known as markers of atheroprotection. Interestingly, 
Krueppel like factor 4 (KLF4)4 was shown to be shear responsive at both time points.58 
Genes that play a key role in the initiation of atherosclerosis were consistently down-reg-
ulated, such as connective tissue growth factor, which mirrors some of the effects of TGFβ, 
ET1, and MCP1.58 Dekker et al. extended these experiments by shearing HUVECs with 
either steady flow (25 dyne/cm2) or pulsatile flow (12 ± 7 dyne/cm2) for 24 h and up to 7 
days. Twelve of 18 000 genes were identified with significantly altered expression (more 
than five-fold), among these, the authors measured that endothelial nitric oxide synthase 
(eNOS), thrombomodulin, cytochrome P450, diaphorase 4, PECAM1, and regulators of G-
protein expression were up-regulated. KLF4 expression could not be detected, but the 
shear-dependent up-regulation of KLF2 was shown for the first time.57 In line with the 
emerging shear susceptibility theory, inflammatory and thrombogenic markers, such as 
VCAM1,were down-regulated.57 Chiu et al. expanded the experimental conditions by an ad-
ditional administration of tumor necrosis factor (TNF)-α after exposure to static, high-level 
shear stress (HSS, 20 dyne/cm2) or a low level of shear stress (LSS, 0.5 dyne/cm2) for 24 h.54 
They concluded that pre-shearing of ECs decreased the TNF-α responsiveness of many 
pro-inflammatory, pro-coagulant, proliferative, and pro-apoptotic genes, whereas it in-
creased the responsiveness of some anti-oxidant, anti-coagulant, and anti-apoptotic genes. 
HSS exposure combined with TNF-β infusion led to the expression of anti-oxidants such 
as eNOS, cytochrome P450, haemeoxygenase 1, thrombomodulin, and KLF4, while inflam-
matory markers, such as Eselectin, VCAM1, TGF-β, BMP4, and cyclins, were down-regu-
lated.54,68 Hence, from these early pioneering studies, it may be concluded that shear stress 
provides an anti-atherogenic gene profile and that these effects are partly regulated 
through pathways shared with TGF-β. 
In 2006, Dekker et al.51 further investigated the role of KLF2 and used a lentiviral system 
to constitutively over-express KLF2, without exposure to shear. They could determine 
KLF2-dependent over-expression of atheroprotective genes, such as eNOS, thrombo-
modullin, MAPK9, and von Willebrand factor and of pro-atherogenic factors such as nu-
clear factor-kappaB (NF-kB), BMP4, interleukin8 (IL8), and SERPINE1 were down-regulated.51 
Interestingly, 42 endothelial signature genes, including vascular endothelial growth factor 
(VEGF)-receptor1/2, Tie-like receptor tyrosine kinase 1/2 (Tie1/2), platelet-derived growth 
factor, their ligands, and VE-cadherin, were not significantly affected by KLF2.51 Parmar et 
al.69 added complexity to the shear regimes by modelling an atheroprotective and athero-
prone shear stress waveform to which HUVECs were exposed for 24 h. They also over-
expressed KLF2 with an adenovirus and investigated the response to IL-1β. KLF2 was 
highly up-regulated in response to shear stress with the atheroprotective waveform. Genes 
that were down-regulated by KLF2, but not modulated by IL-1β, included Ang-2 and ET1, 
while nuclear factor of activated T-cells cytoplasmic-dependent (NFATc3), eNOS, and 
ASS1 were down-regulated. Genes that were up-regulated by IL-1β and antagonized by 
KLF2 included IL-6, VCAM-1, and tissue factor. Genes that were synergistically up-regulated 
by both stimuli were PI3K, prostaglandin E synthase (PTGDS) 1 and VEGF. The group 
further demonstrated with other experiments that KLF2 expression is regulated by the ac-
tivation of a MEK5/ERK5/MEF2 pathway. Conway et al.70 compared the transcriptional 
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profile of HUVECs after 24 h exposure to one of the three shear regimes: reversing shear 
stress (RVSS; 1 ± 11 dyne/cm2), HSS (15 dyne/cm2), and LSS (1 dyne/cm2).70 They found that 
in comparison with static conditions, the RVSS and LSS exhibited a similar pattern. Up-
regulated genes were metallothionein 1 and cell cycle genes such as cyclin B3, cytochrome 
P450, and syndecan 1, whereas KLF2 and natriuretic peptide receptor A (NPR1) were 
down-regulated. In the high-shear scheme, KLF2 expression was not enhanced, while 
KLF4, MEF2, and TGFβ were significantly up-regulated.70 
In 2010, Villarreal et al.71 addressed for the first time the issue of partially overlapping 
roles of KLF2 and KLF4 in response to shear stress or an upstream stimulus of constitu-
tively expressed MEK5. They combined over-expression studies of KLF2 and KLF4 and 
discovered that 59.2% of genes regulated by the activation of MEK5 were similarly con-
trolled by KLF2 or KLF4. These genes were either coordinated in a combinatorial approach 
or individually independent of MEK5.71 MEK5/KLF2-dependent up-regulated genes were 
CD59, 2′, 3′-cyclic nucleotide 3′ phosphodiesterase, and PTGDS, whereas BMP4 was down-
regulated. Cathepsin B, sex-determining region Y-box 7, and VEGF were over-expressed 
in dependence of MEK5/KLF4, whereas INFg-inducible protein 16 was down-regulated. A 
synergistic up-regulation could be observed for TIE-2, ASS1, nephroblastoma overex-
pressed (NOV), whereas MCP1 and IL8 were down-regulated. 
There might be a subtle difference between genes responding to flow from static culture 
vs. those that react to varying levels of flow. The first experimental condition could detect 
non-specifically, up-regulated genes and thereby over-estimate the number of genes that 
are regulated by flow. Two in vitro studies employed multiple flow levels and they have 
been used to test this idea.72,73 Unfortunately, despite close similarities in experimental de-
sign between both studies, the different microarrays and bioinformatic analyses make 
these studies difficult to compare. Dolan et al. employed the philosophy that a reduction 
of the data space [clustering with principal component analysis before applying a gene 
enrichment analysis (GSEA)] increases the power of the tests, while White et al. just ap-
plied a subjective cut-off of 300 differentially regulated genes. As a consequence, Dolan et 
al. report 132 genes regulated by the different flow levels vs. 303 genes reported by White 
et al. Dole et al. also showed that more genes are regulated by comparing static to low or 
static to high flow, suggesting, but certainly not proving, that non-specific genes may be 
up-regulated by the initiation of flow from a static condition. Among the up-regulated 
genes in White’s study were transcription factors (ATF and KLF), members of the MAPK 
pathways, vasodilators such as ET1 and COX. Unfortunately, these genes were not up-
regulated in Dolan et al., which may be due to different vascular beds (see later), different 
species, different developmental stages (embryonic vs. adult), and/or the bioinformatics 
schemes. The resemblance of White’s study with previous studies provides strong evi-
dence that the above-mentioned genes are regulated by blood flow. 
In summary, the aforementioned studies indicate that ~10% of genes in cultured ECs 
are induced by a sudden step in flow (from static conditions, Table 1), while fewer genes 
(3–6%) are regulated by the actual flow level (see studies of White et al. and Dolan et al. in 
Table 1). These studies differed substantially on a single gene level; however, the nature of 
the flow-regulated gene signatures in cultured ECs confirms the concept of EC priming by 
blood flow.74 In this concept, blood flow confers protection by decreasing pro-atherogenic, 
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pro-inflammatory, and prothrombotic gene profiles. As priming depends on the actual 
level of blood flow, one can infer that low–shear stress regions offer less protection at the 
known predilection sites for atherosclerosis. 
 
6. Microarray studies of ECs obtained from intact vascular tissue 
 
Far fewer in vivo studies reported a genome-wide analysis of mechanosensitive path-
ways.75–80 One of the first reports, which studied changes in mechanosensitive gene profiles 
in non-hypercholesteraemic pigs, was conducted by Passerini et al.76 They compared dis-
turbed flow with undisturbed flow in porcine aortic arches and identified ~2000 genes to 
be affected by the flow field, applying a platform with low coverage (Table 1). Through a 
GSEA, they extended the priming concept of flow on ECs.76 More recently, Zhang et al. 
investigated the differences between porcine coronary ECs (CECs) gene profiles, which 
were derived from a more atheroprone vessel, and iliac artery-derived cells (IECs). Com-
paring the gene expression patterns of CECs vs. IECs, many inflammatory and thrombo-
genic genes were up-regulated, such as DUSP1, ICAM-1, activated leucocyte cell adhesion 
molecule, PECAM1, E-selectin, NF-kB, and AP-1. Cytoprotective genes such as members 
of the homeobox family HOXA10, HOXA9, HOXD3, and superoxide dismutase 2 as well 
as KLF2 and KLF4were down-regulated. The same group showed that the coronary endo-
thelium has a higher sensitivity to reactive oxygen species (ROS), resulting in more endo-
plasmic reticulum stress.79 Similar studies were conducted by Civelek et al., who showed that, 
next to the effect of flow, a spatial component was present. If they compared the coronary 
vs. the non-coronary endothelium, ~1300 genes were regulated. This result could be at-
tributed to only the specific properties of the vascular bed. However, as a detailed shear 
stress field was not determined in these experiments, it cannot be ruled out that differences 
in flow between coronary and noncoronary sites explain these findings. 
A first mouse high-throughput study was performed by the group of Jo et al. They mod-
ified the flow pattern in the left coronary arteries and isolated ECs at 12, 24, and 48 h from 
both the left (intervention) and right coronary (control). They employed a combination of 
a false discovery rate (FDR) < 10% and an over-expression > 1.5.75 Despite these relaxed 
conditions, they identified only 52 endothelial genes regulated by flow after 12 h, and 583 
genes regulated at 48 h, which is a lower number than reported for the porcine studies 
(Table 1). The reason for this discrepancy is unknown, and may be related to the relatively 
short time frame of their studies, or the lower reduction of shear stress in their intervention 
vessel.75 Interestingly, they identified several previously unknown mechanosensitive 
genes, such as Lmo4, klk10, and dhh.75 
In conclusion, in studies performed with the endothelium from intact tissue, flow-
dependent priming of ECs was detected. With respect to individual gene signatures, it is 
too early to conclude that an intact endothelium reacts differentially from their cultured 
counterparts. Remarkably, the current studies also suggest that in addition to a flow effect, 
a vascular bed-specific effect is present, leaving CECs more sensitive to ROS-induced en-
doplasmic reticulum stress than other vascular beds. 
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7. Microarray analysis of ECs covering atherosclerotic plaques 
 
High-throughput, microarray studies typically utilize measurement techniques based on 
the RNA of a single cell type, which is removed from its natural environment to avoid 
confounding influences. Removal of endothelium either occurs early in the process, where 
the RNA is extracted from cells in culture, or the endothelium is isolated immediately be-
fore RNA extraction as in laser capture dissection. Both of these techniques have draw-
backs, where the culturing process can cause dedifferentiation of the cells, and the long 
duration of cell isolation from tissue may cause RNA degradation. This is why we have 
explored another technique to measure the endothelial genotype called gene deconvolu-
tion. 
Gene deconvolution is an emerging technique to decipher a cellular genotype in com-
plex tissue.81–83 The definition of complex tissue is one that contains multiple cell types 
whose densities potentially change over time—conditions very pertinent for plaque for-
mation. The proposed deconvolution technique assumes that the genes redistribute over 
the different cell types according to their density and their state of ‘activity’, and thereby 
correct for a changing cellular composition of the plaques that enables one to estimate the 
gene profiles of all cell types present in their ‘natural’ environment.80–83 An essential as-
sumption underlying this approach is that nonlinear effects are not present, e.g., that a 
gene in one cell does not amplify gene expression of other cells. Another assumption is the 
absence of strong heterogeneity in cellular subsets, which are conditions not met in ather-
osclerosis. This can be incorporated by adding more (subset) measurements, but since this 
field is in discussion, we have not included this information in the current approach. 
We applied this technique to 24 microarrays obtained from 10 pooled mouse vessels per 
microarray containing TCFAs and non-TCFAs in a similar vascular segment (for details of 
the model, see above and Cheng et al.28). The proposed technique assumes that the cellular 
density is known from the vessel segment of interest, and since this was not available, we 
modified the method by an iterative Bayesian approach to estimate the probability density 
distribution of the individual cell types from cellular data obtained from other vessels (for 
details, see Frueh et al.84). The deconvolution method has been tested in several prior stud-
ies (for details, see Frueh et al.84) and it was applied by us for the first time on murine plaque 
tissue. 
We pretreated our microarrays, aiming at minimizing the data space before applying 
further analysis. We first applied RMA to reduce the number of outliers, diminished gene 
number by non-annotated genes, low-expressing genes, and non-reacting genes (for de-
tails, see Figure 2). As a second step, the iterative Boolean procedure was tested against 
known cell fractions obtained from a separate series of experiments with a good result, 
indicating that the method to generate posterior distribution (PDF) of our cellular plaque 
compositions produced accurate results. Implementing the posterior PDF to the deconvo-
lution method revealed new cell-specific genes that were undetected with the classical 
SAM method. A first analysis, where time and location were taken as independent varia-
bles, revealed that time was not significant. Hence, the time-dependent samples were 
pooled to increase power of the tests. As a result, we only compare stable vs. nonstable 
plaques, independent of their development. The number of genes differentially expressed 
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between vulnerable and stable plaques was 16 645, distributed over VSMCs (1300 genes), 
ECs (6300), T-cells (4900), and macrophages (5100). 
 
 
 
Figure 2. This picture describes the filters used to portray the analysis of the microarrays. 
After normalizing the microarrays with RMA, we performed a principal component anal-
ysis to identify homogeneity of sets of microarrays. Four arrays were found different than 
the clusters identifying each experimental condition and were deleted. The remaining 20 
arrays were filtered using SCAMPA, for low expression using their mean value and for 
the absence of change during experimental intervention using their variance. The remain-
ing probe set was analysed in several ways using SAM, RANKPROD, and ANOVA. 
 
Pathway analysis was performed by applying GSEA, which identified 49 pathways, 4 
of which were activated in both VSMC and ECs, and the remaining 45 pathways were 
exclusively activated in ECs. In contrast to the studies cited above, which were performed 
in cultured nonatherosclerotic cells and normocholesteraemic pigs, the preliminary analy-
sis of the endothelial genotype shows a higher content of pro-atherogenic gene profiles 
with a high activity of the MAPK and PPAR pathways.84 
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8. Bioinformatics analysis as a source of variability 
 
The major aim of this paper was to obtain a robust conclusion on endothelial pathways 
regulated by flow. However, this appeared a complicated and cumbersome task, as exper-
imental conditions varied among studies, platforms were different, and the bioinformatics 
was different across studies. While all components may play a role in the variability among 
the reported studies, a first indication that the bioinformatics appears to play a central role 
in the high variability among studies, came from a comparison of studies that differed 
mainly by bioinformatic analysis. Yee et al.85 and Mun et al.86 who reported similar exper-
imental protocols, differed only at their choice of platform (Agilent and Affymetrix) and 
false discovery rates. They reported shear responsive gene regulation to be different by a 
factor of 3 (1000 and 3000 genes; Table 1). The other two studies,72,73 which compared two 
flow levels (15 and 75 dyne/cm2), showed a two-fold difference in altered gene expression 
with increasing shear stress (300 vs. 600 genes at 15 vs. 75 dyne/cm2). However, in addition 
to a completely different bioinformatic approach (described above), these groups used a 
different platform with different coverage72,73 and different cell types. 
These first comparisons urged us to study the applied bioinformatics in larger detail. At 
first instant, it is clear that most studies employed an RMA-like analysis to correct for out-
liers, followed by an FDR to determine differentially up-regulated genes.57,67,70,78 However, 
at closer inspection, one study did not employ an FDR,65 while others used a combination 
of ANOVA, degree of expression and FDR,58 and others combined FDR with fold expres-
sion.84 Furthermore, the level of FDR was different among studies and sometimes varied 
within a single manuscript. Most studies, subsequently applied GSEA to elucidate signal-
ling pathways. Gene enrichment is appealing but may attribute genes to multiple path-
ways, providing an over-estimate of pathway involvement. 
Recent studies incorporated newer tools to reduce the data space by a stricter prepro-
cessing of data (FARMS73), by abandoning nonannotated and nonresponding genes,84 or 
by the analysis of subgroups after nonhierarchical clustering.73 Recently, the argument of 
having a threshold on the expression level (e.g., FDR) was further relaxed as biological 
importance is now used as a criterion for significance. Biological importance was deduced 
from the presence of a network; e.g., whether other genes responded similarly in expres-
sion79 and modules of these networks were further tested for gene enrichment. These stud-
ies, in general, report much larger gene regulation by blood flow than the studies using 
FDR (Table 1). 
In summary, it seems that the overall sources of error are wide but could be attributed 
predominantly to variations in bioinformatic analysis. It seems good to reach a consensus 
on the approaches used in order to compare the different studies and reach robust conclu-
sions on the presence and regulation of mechanosensitive signalling pathways. 
 
9. Systems biology of mechanosensitive pathways 
 
Despite all of the above considerations, some signalling pathways appeared to be present 
in most studies. These pathways were the inflammatory pathways (MAPK and NF-κB 
pathways61,76) and anti-oxidative pathways (e.g., the eNOS-NO pathway58). Of the 
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transcription factors, KLF2 and KLF4 were quite often regulated by flow, followed by NRF-
2, NF-κB, the ATF-family, p38, and the JNK family.72 KLF2 and KLF4 have attracted a lot 
of attention, and they have been reported to be regulated through the MEK5-ERK5 path-
way.69,87–89 New pathways, present in some studies, are the Notch and Wnt pathways. Fur-
thermore, our first study, dedicated to the signature of ECs covering a plaque, indicated a 
role for the PPAR pathway in the shear-dependent TCFA formation. 
In conclusion, several groups have studied mechanosensitive pathways. Over time, 
these studies became more reliable due to the maturation of the microarray platforms in 
terms of coverage and repeatability of their responses. During the analysis, it appeared 
that conformity of the bioinformatics analysis is absent, which introduces a high variability 
between reported gene signatures. One of the conclusions of this study is that consensus 
between groups on bioinformatics might increase the usage of previous and new experi-
ments. 
Despite these precautions, it seems that ~5–10% of genes are regulated by blood flow, 
whereas the cultured cell studies indicate that the majority of genes (90%) are regulated by 
the steady component of blood flow, and only 10% were regulated by pulsatile conditions. 
The gene signatures could be summarized by a priming concept, where blood flow reduces 
pro-inflammatory, pro-thrombotic, and pro-atherogenic genes. Of the specific signalling 
pathways, the MAPK pathways, the NF-κB, and the eNOS-NO pathways were most often 
mentioned. However, the large variability between the different studies prevents drawing 
robust conclusions on individual signalling pathways. 
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